Export

Infant Bacterial Therapeutics AB

Financial information

The information source is the annual report of the company with business id 556873-8586

* Closing information (×1000) SEK

Fiscal year 202312 202212
Number of months: 12 12
Turnover: 0 0
Financial expenses: 0 Revenue Down 293 Revenue Down
Earnings before taxes: -123,066 Revenue Down -65,451 Revenue Down
Total assets: 351,334 Revenue Up 349,619 Revenue Down
Current assets: 341,563 Revenue Up 339,031 Revenue Down
Current liabilities: 46,180 Revenue Up 17,913 Revenue Up
Equity capital: 305,154 Revenue Down 331,706 Revenue Down
Share capital: 3,672 Revenue Up 3,060
Number of employees: 8 Revenue Up 7 Revenue Down

Financial ratios

Solvency: 86.9% Revenue Down 94.9% Revenue Down
Turnover per employee: 0 0
Profitability: -Infinity% -Infinity%
Return on equity (ROE): -40.3% Revenue Down -19.7% Revenue Down
Current ratio: 739.6% Revenue Down 1.892.7% Revenue Down
Return on assets (ROA): -35.0% Revenue Down -18.6% Revenue Down

Companies with similar products and services, and with detailed information

Fiscal year 202312
Number of months: 12
Turnover: 0
Financial expenses: 0
Earnings before taxes: -123,066
Total assets: 351,334
Current assets: 341,563
Current liabilities: 46,180
Equity capital: 305,154
Share capital: 3,672
Number of employees: 8

Financial ratios

Solvency: 86.9%
Turnover per employee: 0
Profitability: -Infinity%
Return on equity (ROE): -40.3%
Current ratio: 739.6%
Return on assets (ROA): -35.0%